申请人:NIPPON CHEMIPHAR CO., LTD.
公开号:US20210121478A1
公开(公告)日:2021-04-29
A medicament for preventive and/or therapeutic treatment of multiple sclerosis, especially a pain accompanying multiple sclerosis such as neuropathic pain, which contains a compound having a P2X4 receptor antagonist activity such as a compound represented by the general formula (IH), or a salt thereof, or a hydrate or solvate thereof as an active ingredient.